Mar 28 |
Pharma Stock Roundup: ABBV & NVO's New M&As, FDA Nod to JNJ & MRK PAH Drugs
|
Mar 26 |
AbbVie (ABBV) to Buy Landos to Strengthen Autoimmune Portfolio
|
Mar 25 |
Why Is Ulcerative Colitis-Focused Landos Biopharma Stock Trading Higher On Monday?
|
Mar 25 |
Landos shares rocket 170% on AbbVie takeover deal
|
Mar 25 |
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
|
Mar 25 |
AbbVie to buy immune drug developer Landos
|
Mar 21 |
Landos Biopharma reports Q4 results
|
Mar 21 |
Landos Biopharma Provides Business Update and Reports Fourth Quarter and Full Year 2023 Results
|
Mar 5 |
Will Landos Biopharma (NASDAQ:LABP) Spend Its Cash Wisely?
|
Jan 8 |
Landos Biopharma to Present New Data on Immunometabolism at the 19th Annual Congress of the European Crohn’s and Colitis Organisation
|